ReviewClinical and experimental immunology2002
Discovery of immunopotentiatory drugs: current and future strategies.
Review in Clinical and experimental immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- X-ray crystallography and sickle cell disease drug discovery-a tribute to Donald Abraham.Frontiers in molecular biosciences · 2023Review
- Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.Expert opinion on therapeutic patents · 2022Review
- Dendrophthoe pentandra (L.) Miq extract effectively inhibits inflammation, proliferation and induces p53 expression on colitis-associated colon cancer.BMC complementary and alternative medicine · 2016Article
- Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.Accounts of chemical research · 2016Article
- Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.Bioorganic & medicinal chemistry · 2014Article
- Immunomodulatory effects ofExperimental and therapeutic medicine · 2014Article
- Successful treatment of lower eyelid melanoma in situ.Plastic and reconstructive surgery. Global open · 2014Article
- Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.Hematology/oncology clinics of North America · 2014Review
- Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.Proceedings of the National Academy of Sciences of the United States of America · 2010Article
- Article
- Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target.British journal of pharmacology · 2003Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.